brookhaven science associates u.s. department of energy gene-jack wang, m.d. brookhaven center for...
TRANSCRIPT
Brookhaven Science AssociatesU.S. Department of Energy
Gene-Jack Wang, M.D.
Brookhaven Center for Translational Neuroimaging
Obesity & Addiction:
Neuroimaging Studies
Obesity & Addiction:
Neuroimaging Studies
Brookhaven Science AssociatesU.S. Department of Energy
ObesityObesity
Newsday / Walt HandelsmanOct 10, 2002
Brookhaven Science AssociatesU.S. Department of Energy
• Culture, • Genetics,
• High energy intake,• Lowered energy
expenditure,• Abnormal eating
behavior.
Factors Contributing to Obesity
Factors Contributing to Obesity
Brookhaven Science AssociatesU.S. Department of Energy
Extrinsic factors
food-related cue & availability
Emotional factors
Stress, boredom
Intrinsic factors
Leptin, Insulin, Ghrelin, PYY,
Dopamine
Hypothalamus
Signals that Control Food IntakeSignals that Control Food Intake
Brookhaven Science AssociatesU.S. Department of Energy
Many obesity researchers focus on how the body's fuel and fat levels control appetite. But as comfort eaters know, habits and desires often override metabolic need.
Eating HabitsEating Habits
Brookhaven Science AssociatesU.S. Department of Energy
Body Weight & Drug Treatment
Body Weight & Drug Treatment
•Drugs (stimulants: e.g. amphetamine, cocaine, methylphenidate) that increase brain dopamine concentration are anorexigenic.
•Drugs (antipsychotic: e.g. Haloperidol,.. ) that block dopamine D2 receptors increase appetite and result in significant weight gain.
Brookhaven Science AssociatesU.S. Department of Energy
Cocaine Alcohol Heroin
AbuserControl
[11C]raclopride
Abuser AbuserControl Control
Dopamine D2 images of Drug Addiction
Dopamine D2 images of Drug Addiction
Brookhaven Science AssociatesU.S. Department of Energy
Non Drug Abuser
Addicted Subject
DA
DA
DA
DA DA DA
DA
Reward CircuitsReward Circuits
DA
DA
DA
DA Dopamine
DA
DA DA DA DA
DA
Dopamine
Low Dopamine (DA) State in Addiction
Low Dopamine (DA) State in Addiction
Brookhaven Science AssociatesU.S. Department of Energy
•Compulsive overeating shares many of the same characteristics as drug addiction.
ObesityObesity
•Do obese subjects have abnormal dopamine receptors?
Brookhaven Science AssociatesU.S. Department of Energy
Control Subjects
2
0
ml/gm
Obese Subjects
Dopamine ReceptorsDopamine Receptors[11C]raclopride
Wang et al, Lancet 2001
Brookhaven Science AssociatesU.S. Department of Energy
p < 0.002 • Obese subjectso Control subjects
Dopamine Receptor and BMI
Dopamine Receptor and BMI
Dopamine Receptor Concentration
BMIp = 0.3
Wang et al, Lancet 2001
Brookhaven Science AssociatesU.S. Department of Energy
• Dopamine modulates motivation and reward circuits and hence dopamine deficiency in obese subjects may perpetuate pathologic eating as a means to compensate for the decreased activation of reward circuits.
ImplicationImplication
Brookhaven Science AssociatesU.S. Department of Energy
movement
addiction Reward & well-being
DopamineDopamine
motivation
Brookhaven Science AssociatesU.S. Department of Energy
•Eating is highly reinforcing behavior, just like taking drugs and as for drugs it can elicit powerful conditioned responses.
FoodFood
•Are the conditioned responses associated with DA release? That is would DA be released by viewing food without eating it?
Brookhaven Science AssociatesU.S. Department of Energy
1) Subjects were asked to describe their favorite foods and how they like to eat them while they were presented with foods that they had reported as among their favorite ones.
2) Food was warmed to enhance the smell and the subjects were presented with it so that they could view it and smell it and a cotton swab impregnated with the food was placed in their tongues so they could taste it.
3) A given food item was presented for 4 minutes and then it was exchanged for a new one.
Food StimulationFood Stimulation
Brookhaven Science AssociatesU.S. Department of Energy
Subjects viewed neutral images and/or were asked to describe in as much detail as possible their family genealogy.
Neutral StimulationNeutral Stimulation
Brookhaven Science AssociatesU.S. Department of Energy
Methylphenidate ( MP) block
the Dopamine Transporter ( )
Methylphenidate ( MP) block
the Dopamine Transporter ( )
DA
DA
DA
DA DA DA
DA
signal
DA
DA
DA
DA DA DA
DA
signal
DA
DA
DA
DADADA DA
DA
DA DA
DA
DA
DA
MP enhances weak signals
MP
Brookhaven Science AssociatesU.S. Department of Energy
Subjects were scanned 4 times with [11C]raclopride over a two day period. Six subjects participated study 1 on the first day and four subjects participated study 2 on the first day of the studies
Study 1
Placebo
Food
[11C]raclopride
PET scan
Ritalin (20mg, po)
Neutral
[11C]raclopride
PET scan
Study 2
Placebo
Neutral
[11C]raclopride
PET scan
Ritalin (20mg, po)
Food
[11C]raclopride
PET scan60 min.
A B
C D
Study DesignStudy Design
Brookhaven Science AssociatesU.S. Department of Energy
Brain Dopamine Response to Food Stimulation
Brain Dopamine Response to Food Stimulation
DA
D2
Recep
tor
Availab
ilit
y(B
max/K
d)
2.5
3
3.5
4
Placebo/NeutralPlacebo/Food MP/Neutral MP/Food
p < 0.11p < 0.02
p < 0.005
1.5
0
ml/g
Sum images of 10 normal weight subjects ([11C]raclopride)
Volkow, Wang, et al, Synapse 2002
Brookhaven Science AssociatesU.S. Department of Energy
0 5 10 15 20 25 30-2
0
2
4
6
8
10
Hu
ng
er
-2
0
2
4
6
8
10
0 5 10 15 20 25 30
Desir
e f
or
Food
% Change Bmax/kd
Extracellular DA vs Self-report of Hunger & Desire for Food + Ritalin
Extracellular DA vs Self-report of Hunger & Desire for Food + Ritalin
r = 0.76p < 0.01
Volkow, Wang, et al, Synapse 2002
Brookhaven Science AssociatesU.S. Department of Energy
These results support the role of DA neurotransmission in dorsal striatum in mediating food motivation in human brain.
ImplicationImplication
Brookhaven Science AssociatesU.S. Department of Energy
Food Presentation
Neutral PresentationRight
85
0µmol/100g/min
Brain Metabolic Response to Food Stimulation
Brain Metabolic Response to Food Stimulation
Wang et al, Neuroimage 2004
18FDG
Brookhaven Science AssociatesU.S. Department of Energy
SS
In ST
OF
Statistical Parameter Map of Metabolic Changes between Food and Neutral
stimulation
Statistical Parameter Map of Metabolic Changes between Food and Neutral
stimulation
R
Wang et al, Neuroimage 2004
Twelve normal weight subjects.
Insula is a brain region modulating emotional responses to appetitive stimuli.
Orbitofrontal cortex is a brain region involved with salience attribution.
Brookhaven Science AssociatesU.S. Department of Energy
Metabolism in orbitofrontal cortex during food stimulation
Metabolism in orbitofrontal cortex during food stimulation
% M
etab
olic
Cha
nges
-10
-5
0
5
10
15
20
25
-10 0 10 20 30 40 50 60 70 80
% Changes of feeling of hunger
r = 0.84, p = 0.001
Wang et al, Neuroimage 2004
Orbitofrontal cortex is a brain region involved with salience attribution and drive, may underlie the motivation to procure food, which may be subjectively experienced as “desire for food” and “hunger”.
Brookhaven Science AssociatesU.S. Department of Energy
ImplicationImplication• The enhanced orbitofrontal cortex
activation by food stimulation may reflect downstream effects from dopamine stimulation.
• Dopaminergic involvement in the drive for food consumption in humans is in part mediated by its effects in orbitofrontal cortex.
• The results could explain the deleterious effects of constant exposure to food stimuli (e.g. advertisements, candy machines, food channels, stores) in overeating.
Brookhaven Science AssociatesU.S. Department of Energy
Neutral Theme Interview
Cocaine Theme Interview
85
0
µmole/100g/min
Brain Activation during Cocaine Theme InterviewBrain Activation during
Cocaine Theme Interview
18FDG
Orbitofrontal Activation
Wang et al, Life Science 1999
Brookhaven Science AssociatesU.S. Department of Energy
² Craving (0-10)
² µm
ol/1
00g/
min
-15-10
-505
101520253035
-2 0 2 4 6 8 10 12% Metabolic changes
% P
ulse
rat
e ch
ange
s0
5
10
15
20
25
30
-40 -20 0 20 40 60 80 100120140160
Cocaine Craving & Insular Metabolism
Cocaine Craving & Insular Metabolism
Wang et al, Life Science 1999
- Right Insula, p < 0.01
O - Left Insula, p < 0.008
p < 0.0002
Brookhaven Science AssociatesU.S. Department of Energy
Activation of the temporal insula, a brain region involved with autonomic control, and of the orbitofrontal cortex, a brain region involved with expectancy and salience attribution, during the cocaine theme support their involvement with craving in cocaine addicted subjects.
ProspectiveProspective
Brookhaven Science AssociatesU.S. Department of Energy
•What makes obese subjects different from drug abusers?
ObesityObesity
VS
Drug Abuse
Brookhaven Science AssociatesU.S. Department of Energy
•Would obese subjects have an enhanced sensitivity in the brain regions involved with sensory processing of the food?
ObesityObesity
Brookhaven Science AssociatesU.S. Department of Energy
55
0µmol/100g/min
Control subjects Obese subjects
R L
Averaged FDG images
Averaged FDG images
What brain regions differ?Wang et al, NeuroReport 2002
Brookhaven Science AssociatesU.S. Department of Energy
Enhanced Somatosensory Cortex Metabolism in Obese Subjects
Enhanced Somatosensory Cortex Metabolism in Obese Subjects
Ten obese subjects (n = 10, BMI > 40) and 25 lean subjects (BMI < 25).
At baseline condition after fasting for 14-16 hours.
Obese subjects had higher metabolism than lean subjects in the somatosensory areas where the mouth, lips and tongue are represented.
FDG
Wang et al, NeuroReport 2002
Brookhaven Science AssociatesU.S. Department of Energy
• The enhanced activation in somatic parietal areas for mouth, tongue and lips in obese subjects suggests that enhanced sensitivity in regions involved in the sensory processing of food may make food more rewarding and may be one of the variables contributing to their excess food consumption.
ImplicationImplication
Brookhaven Science AssociatesU.S. Department of Energy
BiologyGenes
Addiction
EnvironmentDrug or
Behavior
AddictionAddiction
Brookhaven Science AssociatesU.S. Department of Energy
ScientistsJoanna Fowler (organic chemist)David Alexoff (engineer)Helene Benveniste (anesthesiologist)Anat Biegon (pharmacologist)Stephen Dewey (anatomist)Yu-Shin Ding (organic chemist)Richard Ferrieri (physical chemist)S. John Gatley (pharmacologist)Rita Goldstein (psychologist)Kuo-Shan Lin (organic chemist)Jean Logan (theoretical chemist)Yeming Ma (physical chemist)David Schlyer (inorganic chemist)Michael Schueller (biomedical physicist)Frank Telang (neurologist)Peter Thanos (neuroscientist)Paul Vaska (physicist)Nora Volkow (psychiatrist)Gene-Jack Wang (nuclear med physician)
Support StaffKaren Apelskog (protocol coordinator)Pauline Carter (nurse)Victor Garza (chemist)Barbara Hubbard (nurse)Millard Jayne (nurse)Payton King (Lab Technician)Hai-Dee Lee (Lab Technician)Noel Netusil (nurse)Colleen Shea (chemist)Azael Villanueva (biomedical engineering) Donald Warner (electronics)Youwen Xu (chemist)Lisa Zimmerman (study coordinator)Post Doctoral/FellowNelly Klein (psychologist)Kim Lindsey (pharmacologist)Igor Izrailtyan (anesthesiologist)Daryn Moeller (anesthesiologist)Alex Morgan (physician)Lisa Cotton (psychologist)
Brookhaven PET GroupBrookhaven PET Group
Brookhaven Science AssociatesU.S. Department of Energy
SupportSupport
Department of Energy(Office of Biology & Environmental Research)
National Institute on Drug Abuse
Office of National Drug Control Policy